Stocks in play: Cipher Pharmaceuticals Inc.
Announced today the appointment of Hamed Ghanei as Chief Business Officer. Dr. Ghanei has over 15 years of experience in specialty pharmaceuticals, venture funds, and healthcare investment banking. Cipher Pharmaceuticals Inc. shares T.CPH are trading up $0.45 at $16.48.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.